tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market

Kymera Therapeutics (KYMR) Revenue

Compare
222 Followers

Kymera Therapeutics Revenue

Kymera Therapeutics had a revenue of 7.39M in the quarter ending Dec 31, 2024, with 97.65%. This bring the company's revenue in the last twelve months to 47.07M, Increased -46.24%. In the fiscal year ending Dec 31, 2024, Kymera Therapeutics had annual revenue of 47.07M with -40.11% growth.
Revenue (ttm)
47.07M
Revenue Growth
-40.11%
P/S Ratio
30.37
Revenue/Employee
$250,383
Employees
188
Market Cap
$1.43B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202447.07M-31.52M-40.11%
Dec 31, 202378.59M31.77M+67.84%
Dec 31, 202246.83M-26.01M-35.71%
Dec 31, 202172.83M38.80M+114.00%
Dec 31, 202034.03M31.10M+1,059.99%
Dec 31, 20192.93M+∞%
Dec 31, 20180.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis